CMG Pharmaceutical Co. Ltd (058820) — Cash Flow Quality Index
CMG Pharmaceutical Co. Ltd (058820) has a Cash Flow Quality Index of -0.71x as of September 2025. Operating cash flow of ₩-4.04 Billion is below net income of ₩5.73 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore CMG Pharmaceutical Co. Ltd cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
CMG Pharmaceutical Co. Ltd Cash Flow Quality Index (2014–2024)
Historical Cash Flow Quality Index for CMG Pharmaceutical Co. Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check CMG Pharmaceutical Co. Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for CMG Pharmaceutical Co. Ltd (2014–2024)
Year-by-year earnings quality comparison for CMG Pharmaceutical Co. Ltd. For live market cap and the full company financial profile, see 058820 company net worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.11x | ₩290.09 Million | ₩2.69 Billion | ▼ -82.2% |
| 2023 | 0.61x | ₩3.91 Billion | ₩6.46 Billion | ▼ -65.9% |
| 2021 | 1.78x | ₩5.63 Billion | ₩3.17 Billion | ▼ -87.0% |
| 2020 | 13.69x | ₩2.94 Billion | ₩215.00 Million | ▲ +1379.9% |
| 2019 | 0.93x | ₩2.82 Billion | ₩3.05 Billion | ▲ +532.9% |
| 2018 | 0.15x | ₩886.78 Million | ₩6.07 Billion | ▼ -78.7% |
| 2017 | 0.69x | ₩1.95 Billion | ₩2.83 Billion | ▼ -48.6% |
| 2016 | 1.34x | ₩2.31 Billion | ₩1.73 Billion | ▼ -70.9% |
| 2014 | 4.59x | ₩724.89 Million | ₩158.04 Million | — |